Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028
Triton’s report has predicted
that the hormone replacement therapy market in North America is probable to
develop at a CAGR of 7.55% in the period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied
in this market are:
• United States
• Canada
North America is
leading the hormone replacement therapy market globally, owing to the
well-developed healthcare infrastructure, coupled with the growing demand for
hormone replacement therapy. Moreover, the implementation of effective rules
and regulations pertaining to the hormone is another factor supporting the
market’s growth. Furthermore, new drug developments, as well as innovations for
growth hormone and testosterone therapy, are adding to the growth of the
hormone replacement therapy market across the North American region.
The approval of several
hormone replacement therapy drugs is estimated to augment the market’s growth
across the US. Moreover, the sales of combined hormonal contraceptives are
relatively high each year, with a significant number of women using a
combination of estrogen and progestin pills. Furthermore, the approval of
several drugs for hormone replacement therapy has supplemented the market’s
growth over the years. This has further generated higher gross revenue,
supporting the hormone replacement therapy market’s future growth within the
United States.
Health Canada approved
hormone replacement therapy products to treat menopausal symptoms, including
night sweats, vaginal dryness, and others. In some cases, it is used to prevent
osteoporosis. Other than this, the surge in the aging population is expected to
boost the growth of the hormone replacement therapy market over the forecast
period. For example, it is estimated that by the age of 80, one in every ten
will be residing in nursing homes. Hence, all these factors are positively
influencing the expansion of the hormone replacement therapy market in Canada.
ANI Pharmaceuticals is
an integrated specialty pharmaceutical company engaged in developing,
manufacturing, and distributing branded and generic prescription pharmaceuticals.
The company targets specific areas of product development, such as narcotics,
oncolytic, hormones, and steroids, among others. It has manufacturing
facilities at various locations having the capability of developing oral dose
products, semi-solids, liquid, and potent products. Serving a broad client
base, ANI has headquartered in Minnesota, the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. NORTH
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. NORTH
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. NORTH
AMERICA HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. NORTH
AMERICA HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: UNITED STATES HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: CANADA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)